Cargando…
Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo
BACKGROUND: Glioblastomas are invasive therapy resistant brain tumors with extremely poor prognosis. The Glioma initiating cell (GIC) population contributes to therapeutic resistance and tumor recurrence. Targeting GIC-associated gene candidates could significantly impact GBM tumorigenicity. Here, w...
Autores principales: | Joel, Mrinal, Mughal, Awais A., Grieg, Zanina, Murrell, Wayne, Palmero, Sheryl, Mikkelsen, Birthe, Fjerdingstad, Hege B., Sandberg, Cecilie J., Behnan, Jinan, Glover, Joel C., Langmoen, Iver A., Stangeland, Biljana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470057/ https://www.ncbi.nlm.nih.gov/pubmed/26081429 http://dx.doi.org/10.1186/s12943-015-0398-x |
Ejemplares similares
-
Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells
por: Stangeland, Biljana, et al.
Publicado: (2015) -
Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells
por: Mughal, Awais A., et al.
Publicado: (2015) -
Expansion of Multipotent Stem Cells from the Adult Human Brain
por: Murrell, Wayne, et al.
Publicado: (2013) -
PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas
por: Zhu, Kejing, et al.
Publicado: (2022) -
PBK/TOPK Expression Predicts Prognosis in Oral Cancer
por: Chang, Chin-Fang, et al.
Publicado: (2016)